Literature DB >> 34636999

Vibrational frequencies and intramolecular force constants for cisplatin: assessing the role of the platinum basis set and relativistic effects.

Caroline A de Almeida1, Larissa P N M Pinto1, Hélio F Dos Santos2, Diego F S Paschoal3.   

Abstract

The role of platinum basis set (PTBS) and relativistic effects for predicting the vibrational frequencies and intramolecular force constants for cisplatin are discussed. Nonrelativistic and relativistic computational protocols were built at B3LYP/PTBS/jorge-DZP/C-PCM and B3LYP-DKH2/PTBS/jorge-DZP-DKH/C-PCM levels, respectively, where 19 distinct PTBS were tested. As expected, the structural parameters were not very sensitive to the PTBS, however, the inclusion of relativistic effects improves the description of the cisplatin structure. When it comes to the vibrational frequencies, the results show that the PTBS, and mainly the relativistic effects, are both important. Moreover, the PBE0 functional led to better results than B3LYP in the protocols PBE0/LANL2TZ(f)/jorge-DZP/C-PCM (P20) and PBE0-DKH2/Sapporo-DKH3-DZP-2012/jorge-DZP-DKH/C-PCM (P22), which provided a mean absolute deviation (MAD) of only 10.8 cm-1 and 9.5 cm-1, respectively, for vibrational frequencies, which are excellent choices to study Pt complexes. Finally, a discussion of the intramolecular force constants for cisplatin is carried out, with the calculated bond and angles force constants with P20 and P22 protocols being recommended for the parameterization of the force field of cisplatin.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Basis set; Cisplatin; Force constants; Raman; Relativistic effects; Vibrational frequencies

Mesh:

Substances:

Year:  2021        PMID: 34636999     DOI: 10.1007/s00894-021-04937-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  22 in total

1.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

Review 2.  The development of platinum compounds and their possible combination.

Authors:  Lara Maria Pasetto; Mario Rosario D'Andrea; Alba Ariela Brandes; Elena Rossi; Silvio Monfardini
Journal:  Crit Rev Oncol Hematol       Date:  2006-06-27       Impact factor: 6.312

Review 3.  A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research.

Authors:  Dorian M Cheff; Matthew D Hall
Journal:  J Med Chem       Date:  2017-02-28       Impact factor: 7.446

Review 4.  Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.

Authors:  D Screnci; M J McKeage
Journal:  J Inorg Biochem       Date:  1999-10       Impact factor: 4.155

5.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

6.  Anticancer metallodrugs: where is the next cisplatin?

Authors:  Muhammad Hanif; Christian G Hartinger
Journal:  Future Med Chem       Date:  2018-02-07       Impact factor: 3.808

Review 7.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

Review 8.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

Review 9.  Platinum-based drugs: past, present and future.

Authors:  Shahana Dilruba; Ganna V Kalayda
Journal:  Cancer Chemother Pharmacol       Date:  2016-02-17       Impact factor: 3.333

10.  Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate.

Authors:  Robbin R Vernooij; Tanmaya Joshi; Evyenia Shaili; Manja Kubeil; Dominique R T Appadoo; Ekaterina I Izgorodina; Bim Graham; Peter J Sadler; Bayden R Wood; Leone Spiccia
Journal:  Inorg Chem       Date:  2016-06-03       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.